EP4196483B1 - 6-((6-Methyl-2-Oxo-1,2-Dihydropyridin-3-Yl)methyl)-7,8-Dihydro-[1,3]dioxolo[4,5-G]isoquinolin-5(6h)-One Derivatives as Ezh1 and Ezh2 Inhibitors for the Treatment of Cancer